None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing PCI at the catheterization laboratory of a participating center Voluntary written informed consent
Exclusion criteria
Exclusion criteria: - Cardiogenic shock: hemodynamic instability that may compromise patient safety with an additional 4 mL blood draw - Severe anemia (hemoglobin <7 g/dL): risk of further hemodynamic compromise from blood sampling - Refusal or inability to provide written informed consent No exclusions are applied based on antiplatelet or anticoagulant regimen, clinical indication, Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score, renal function, or comorbidities, in order to preserve the natural distribution of Korean patients undergoing percutaneous coronary intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composites of all-cause death, myocardial infarction and cerebral infarctio | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinically relevant bleeding event (>=Bleeding Academic Research Consortium (BARC) type 2;urgent revascularization | — |
Countries
Korea, Republic of
Contacts
Seoul National University Bundang Hospital